Enroflox® 10
Thrid-generation quinolone
Injectable Solution
Enrofloxacin 100 mg, excipients q.s.ad. 1 mL
For the treatment of infectious diseases caused by Gram positive and Gram negative bacteria; and mycoplasmas sensitive to enrofloxacin, mainly of the respiratory, genito-urinary and digestive tract, ear canal and skin. Bovine respiratory disease, colibacillosis, salmonellosis, pneumonia, bronchopneumonia, mycoplasmosis, dermatitis, mastitis-metritis-agalactia, rhinitis, among others.
Cattle, sheep, goats, camelids and swines: 1 mL/20-40 Kg, subcutaneous or intramuscular route; horses: its use is controversial, the product recommended at dosage of 1 mL/40 Kg if only a veterinary recommends it. Dogs: 1 mL/20-40 Kg every 12 hours, subcutaneous or intramuscular route. Cats: 0.1 mL/4 Kg or 0.1 mL/2 Kg, subcutaneous or intramuscular route; poultry: 0.15 mL/ Kg intramuscular route.
Bottle x 100 mL .
SENASA Registry: SENASA Perú: F.69.01.N.0009
Print
Insert
Fieldwork
Technical articles
ShareThis content is informative reference and should not be considered as prescriptions.
